New Approach to Treating Fibromyalgia by Addressing Sleep Problems Leads to Patient Improvement
Dr. Lederman, of Tonix Pharmaceuticals, says that by treating sleep problems in fibromyalgia patients, symptoms of the entire syndrome improve.
He pointed out that opiate addiction is a major problem among chronic pain sufferers and acknowledged that fibromyalgia has not been optimally treated by the medical community.
The National Institutes of Health estimates that there are five million Americans with fibromyalgia.
He added that the growing drug market for fibromyalgia is $1.2 billion a year and that only the U.S. and Canada have approved drugs to treat fibromyalgia. Only three drugs are indicated for fibromyalgia, none of which have been shown to address the underlying sleep disturbance that is a hallmark of the disorder. Read full article.